Background illustration for clinical trials search

Leukemia Clinical Trials

Browse 1,314 Leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Clovis CA, Sacramento CA
Sponsor: Brian Jonas

Sex: All

Age: 18+

Code: NCT04905810

Phase2, Recruiting

Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia, Pediatric
Location: Washington DC
Sponsor: Children's National Research Institute

Sex: All

Age: 7+

Code: NCT06722638

Recruiting

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

for
Acute Myeloid Leukemia
Location: Columbus OH
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 24

Code: NCT05503134

Phase1, Phase2, Recruiting

PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies

for
Follicular Lymphoma,
Location: Louisville KY
Sponsor: Qilu Puget Sound Biotherapeutics (dba Sound Biologics)

Sex: All

Age: 18+

Code: NCT05003141

Phase1, Recruiting

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

for
Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS
Location: Maywood IL
Sponsor: Patrick Stiff

Sex: All

Age: 2 - 70+

Code: NCT02124174

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation

Sex: All

Age: 65+

Code: NCT02802267

Phase2, Recruiting

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Houston TX
Sponsor: Cyclacel Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT01211457

Phase1, Phase2, Recruiting

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

for
Acute Lymphocytic Leukemia
Location: Bronx NY, Buffalo NY, Houston TX
Sponsor: Callisto Pharmaceuticals

Sex: All

Age: 15+

Code: NCT00271063

Phase1, Phase2, Recruiting

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

for
MYELODYSPLASTIC SYNDROME; MDS, ACUTE MYELOID LEUKEMIA; AML
Location: Chicago IL, Salt Lake City UT, Seattle WA, Portland OR,
Sponsor: Jasper Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04429191

Phase1, Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

for
Acute Lymphoblastic Leukaemia
Location: Montreal, Toronto, Vancouver
Sponsor: St. Anna Kinderkrebsforschung

Sex: All

Age: 0 - 18

Code: NCT01949129

Phase2, Phase3, Recruiting

Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding

for
Acute Leukemia, Acute Myeloid Leukemia (AML),
Location: Hamilton
Sponsor: Donald Arnold

Sex: All

Age: 18+

Code: NCT06947044

Recruiting

Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS

for
Acute Myelogenous Leukemia, Myelodysplastic Syndromes
Location: Miami FL, Gainesville FL, Westwood KS, Los Angeles CA
Sponsor: Mateon Therapeutics

Sex: All

Age: 18+

Code: NCT02576301

Phase1, Phase2, Recruiting

Mismatched Donor Cells to Treat Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Montreal
Sponsor: Maisonneuve-Rosemont Hospital

Sex: All

Age: 18+

Code: NCT01793025

Phase1, Recruiting

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

for
Castrate Resistant Prostate Cancer, NUT Carcinoma,
Location: Boston MA, Jacksonville FL, Rochester MN, Houston TX,
Sponsor: Epigenetix, Inc.

Sex: All

Age: 18+

Code: NCT05488548

Phase1, Recruiting

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Columbus OH, Cincinnati OH, Goshen IN, Dallas TX
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04502394

Phase1, Phase2, Recruiting

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Grand Rapids MI, Los Angeles CA
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT07424833

Phase1, Recruiting

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

for
Acute Myeloid Leukemia (AML)
Location: New York NY, Augusta GA, Fairway KS, Houston TX,
Sponsor: Bio-Path Holdings, Inc.

Sex: All

Age: 18+

Code: NCT02781883

Phase2, Recruiting

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

for
Acute Myeloid Leukemia/Myelodysplastic Syndrome,
Location: Buffalo NY, Tampa FL
Sponsor: Celyad Oncology SA

Sex: All

Age: 18+

Code: NCT03018405

Phase1, Phase2, Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

for
B-Cell Lymphoma, B Acute Lymphoblastic Leukemia,
Location: Pittsburgh PA
Sponsor: John Lister

Sex: All

Age: 18 - 70+

Code: NCT05281809

Phase2, Recruiting

TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia

for
Chronic Myelogenous Leukemia
Location: Houston TX, Seattle WA
Sponsor: Shenzhen TargetRx, Inc.

Sex: All

Age: 18+

Code: NCT06088888

Phase1, Recruiting

What are clinical trials for leukemia?

Clinical trials for leukemia are research studies designed to evaluate new treatments, therapies, or diagnostic methods for different types of leukemia, a group of cancers that affect the blood and bone marrow. These trials aim to discover more effective ways to treat leukemia, manage its symptoms, and improve patient outcomes. They may involve testing new drugs, combinations of existing treatments, targeted therapies, immunotherapies, or novel approaches like gene therapy.

Why are leukemia clinical trials important?

Leukemia clinical trials are crucial because they drive advancements in treatment by testing new therapies, improving existing ones, and exploring novel approaches to manage and potentially cure the disease. These trials provide essential data on the safety and effectiveness of new treatments, which can lead to better outcomes and fewer side effects compared to current options.

Types of clinical trials for leukemia

Why participate in a leukemia clinical trial

Who can participate in a clinical trial for leukemia?

How to enroll in a leukemia clinical trial